The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Walkey Carl since 2021.
This trader's CIK number is 1843189.
At the time of last reporting, Walkey Carl was the Senior Vice President of Neoleukin Therapeutics, Inc.. (stock ticker symbol NLTX).
Also see all insider trading activities at Neoleukin Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | NLTX | 0 | $0 | 34,200 | $418,607 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-16 | NLTX | Sale | 600 | 10.19 | 6,114 |
| 2021-06-08 | NLTX | Sale | 600 | 11.00 | 6,600 |
| 2021-06-04 | NLTX | Sale | 600 | 10.00 | 6,000 |
| 2021-05-26 | NLTX | Sale | 600 | 10.00 | 6,000 |
| 2021-05-19 | NLTX | Sale | 600 | 10.63 | 6,378 |
| 2021-05-12 | NLTX | Sale | 1,200 | 11.09 | 13,308 |
| 2021-05-05 | NLTX | Sale | 1,200 | 11.30 | 13,560 |
| 2021-04-28 | NLTX | Sale | 2,400 | 12.58 | 30,192 |
| 2021-04-26 | NLTX | Sale | 600 | 13.00 | 7,800 |
| 2021-04-21 | NLTX | Sale | 1,800 | 11.98 | 21,564 |
| 2021-04-14 | NLTX | Sale | 1,800 | 12.22 | 21,996 |
| 2021-04-07 | NLTX | Sale | 1,800 | 12.02 | 21,636 |
| 2021-04-05 | NLTX | Sale | 600 | 13.00 | 7,800 |
| 2021-03-31 | NLTX | Sale | 1,800 | 11.96 | 21,528 |
| 2021-03-24 | NLTX | Sale | 1,800 | 11.95 | 21,515 |
| 2021-03-22 | NLTX | Sale | 600 | 12.00 | 7,200 |
| 2021-03-17 | NLTX | Sale | 1,200 | 11.36 | 13,632 |
| 2021-03-10 | NLTX | Sale | 1,800 | 11.97 | 21,540 |
| 2021-03-03 | NLTX | Sale | 1,800 | 11.87 | 21,360 |
| 2021-02-25 | NLTX | Sale | 600 | 13.00 | 7,800 |
| 2021-02-24 | NLTX | Sale | 1,800 | 12.14 | 21,852 |
| 2021-02-17 | NLTX | Sale | 2,400 | 12.70 | 30,480 |
| 2021-02-10 | NLTX | Sale | 3,000 | 14.20 | 42,600 |
| 2021-02-05 | NLTX | Sale | 600 | 14.00 | 8,400 |
| 2021-02-03 | NLTX | Sale | 2,400 | 13.23 | 31,752 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Walkey Carl (Senior Vice President of Neoleukin Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.